Tempest Therapeutics, Inc. (TPST)
2.89
+0.01
(+0.35%)
USD |
NASDAQ |
Jan 09, 16:00
2.85
-0.04
(-1.38%)
After-Hours: 20:00
Tempest Therapeutics Market Cap: 10.64M for Jan. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 16.63M |
| AIM ImmunoTech, Inc. | 0.9869M |
| IGC Pharma, Inc. | 27.89M |
| NovaBay Pharmaceuticals, Inc. | 2.414B |
| Protalix Biotherapeutics, Inc. | 166.47M |
Market Cap Related Metrics
| PEG Ratio | -0.0005 |
| Price to Book Value | 1.677 |
| Price | 2.89 |
| Earnings Yield | -349.6% |
| PEGY Ratio | -0.0005 |